Company intelligence / Profile preview

Asian Integrated Cell Laboratory

Ownership: Private
Development stage: Other

Overview

Asian Integrated Cell Laboratory is the world’s largest autoimmune cell bank and the only global facility offering both immune and stem cell dual-system clinical banking. It provides high-standard, GMP-compliant storage, testing, enhancement, and application of human cells for healthcare management. Over 53,000+ tests have been performed[2][6]. Clinical trial results are not specifically disclosed; the focus is on service provision rather than drug development.

Modalities: Stem cell therapyImmune cell therapyCell therapy (general)
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Asian Integrated Cell Laboratory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asian Integrated Cell Laboratory.

Explore the full profile